Pharma's First Cash Grab Hep B at Birth

The Hepatitis B vaccine for newborns was never about protecting most babies.  It was a masterstroke by Big Pharma to hook an entire population into the vaccine pipeline from day one. Back in the 1980s, Merck and other giants saw a goldmine.  Hep B is a virus mostly spread through sex, IV drug use, or infected blood, yet they convinced the CDC to recommend universal infant vaccination. By 1991, it was on the schedule and administered within 12-24 hours of birth, even though the risk to a newborn from a non-infected mother is effectively zero. How did they sell it? "Prevention is better than cure," but the math never added up. Infant infection rates were already plummeting due to screening pregnant women and safer medical practices. 

This isn’t medicine.  It’s marketing dressed as public health. Fear of a rare (mother-to-child) infection is weaponized to justify aluminum-adjuvanted injections into fragile immune systems before they’ve even left the hospital. Meanwhile, the actual risk to a baby born to a Hep B-negative mother, confirmed by prenatal testing, is lower than being struck by lightning. Yet the fear persists, pushed by hospital protocols and pharma-funded studies. It’s time to demand logic over panic.  An infant's first shot shouldn’t be a sales pitch.
As always, do your research!
Much Love, Lynn 
Looking to support the blog with a one time tip? You can donate via PayPal or Buy Me A Coffee

Cryptos are on FIRE right now.  Join my Free Pi Crypto team and get your piece of the pie! 

Want exclusive content that Blogger can't handle?  See me on the following platforms:  Patreon, SubscribeStar, Substack, Buy Me A Coffee, Truth Social and X (formerly Twitter)

         Stay connected!!  Please join me on the Telegram Channel or Telegram Chat